Identification of a constitutional mutation in the WT1 gene in Taiwanese patients with Wilms tumor


The overall frequency of WT1 gene alterations in Wilms tumor is still unclear in Taiwan. Here we conducted molecular genetic analysis of the WT1 gene in Taiwanese patients with Wilms tumor. Polymerase chain reaction and direct sequencing were performed on DNA samples from blood and paraffin-embedded tumor specimens. A constitutional mutation in the WT1 gene was found in one DNA sample from peripheral blood lymphocytes. The remaining DNA samples from peripheral blood lymphocytes and paraffin-embedded tumor specimens were tested negative for both constitutional mutations and somatic mutations. Thus, mutations at other Wilms tumor loci may play an important role in Wilms tumor development.

Share and Cite:

Lu, M. , Wang, W. , Lin, C. , Chang, A. and Lai, Y. (2014) Identification of a constitutional mutation in the WT1 gene in Taiwanese patients with Wilms tumor. Advances in Bioscience and Biotechnology, 5, 230-234. doi: 10.4236/abb.2014.53029.

Conflicts of Interest

The authors declare no conflicts of interest.


[1] Brown, K.W. and Malik, K.T. (2001) The molecular biology of Wilms tumour. Expert Reviews in Molecular Medicine, 2001, 1-16.
[2] Pastore, G., Znaor, A., Spreafico, F., Graf, N., Pritchard-Jones, K. and Steliarova-Foucher, E. (2006) Malignant renal tumours incidence and survival in European children (1978-1997): Report from the Automated Childhood Cancer Information System project. European Journal of Cancer, 42, 2103-2114.
[3] Coppes, M.J. and Egeler, R.M. (1999) Genetics of Wilms’ tumor. Seminars in Urologic Oncology, 17, 2-10.
[4] Rahman, N., Arbour, L., Houlston, R., Bonaiti-Pellie, C., Abidi, F., Tranchemontagne, J., Ford, D., Narod, S., Pritchard-Jones, K., Foulkes, W.D., Schwartz, C. and Stratton, M.R. (2000) Penetrance of mutations in the familial Wilms tumor gene FWT1. Journal of the National Cancer Institute, 92, 650-652.
[5] Menke, A., van der Eb, A.J. and Jochemsen, A.G. (1998) The Wilms’ tumor suppressor WT1: Approaches to gene function. Kidney International, 53, 1512-1518.
[6] Call, K.M., Glaser, T., Ito, C.Y., Buckler, A.J., Pelletier, J., Haber, D.A., Rose, E.A., Kral, A., Yeger, H., Lewis, W.H., Jones, C. and Housman, D.E. (1990) Isolation and characterization of a zinc finger polypeptide gene at the human chromosome 11 Wilms’ tumor locus. Cell, 60, 509-520.
[7] Gessler, M., Konig, A. and Bruns, G.A. (1992) The genomic organization and expression of the WT1 gene. Genomics, 12, 807-813.
[8] Madden, S.L., Cook, D.M., Morris, J.F., Gashler, A., Sukhatme, V.P. and Rauscher 3rd, F.J. (1991) Transcriptional repression mediated by the WT1 Wilms tumor gene product. Science, 253, 1550-1553.
[9] Huff, V. (1998) Wilms tumor genetics. American Journal of Medical Genetics, 79, 260-267.<260::AID-AJMG6>3.0.CO;2-Q
[10] Gessler, M., Konig, A., Arden, K., Grundy, P., Orkin, S., Sallan, S., Peters, C., Ruyle, S., Mandell, J., Li, F., Cavenee, W. and Bruns, G. (1994) Infrequent mutation of the WT1 gene in 77 Wilms’ Tumors. Human Mutation, 3, 212-222.
[11] Segers, H., Kersseboom, R., Alders, M., Pieters, R., Wagner, A. and van den Heuvel-Eibrink, M.M. (2012) Frequency of WT1 and 11p15 constitutional aberrations and phenotypic correlation in childhood Wilms tumour patients. European Journal of Cancer, 48, 3249-3256.
[12] Little, M., and Wells, C. (1997) A clinical overview of WT1 gene mutations. Human Mutation, 9, 209-225.<209::AID-HUMU2>3.0.CO;2-2
[13] Breslow, N.E., Olson, J., Moksness, J., Beckwith, J.B. and Grundy, P. (1996) Familial Wilms’ tumor: A descriptive study. Medical and Pediatric Oncology, 27, 398-403.<398::AID-MPO2>3.0.CO;2-H
[14] Varanasi, R., Bardeesy, N., Ghahremani, M., Petruzzi, M.J., Nowak, N., Adam, M.A., Grundy, P., Shows, T.B. and Pelletier, J. (1994) Fine structure analysis of the WT1 gene in sporadic Wilms tumors. Proceedings of the National Academy of Sciences of the United States of America, 91, 3554-3558.
[15] Menke, A.L., van der Eb, A.J. and Jochemsen, A.G. (1998) The Wilms’ tumor 1 gene: Oncogene or tumor suppressor gene? International Review of Cytology, 181, 151-212.
[16] Rauscher 3rd, F.J. (1993) The WT1 Wilms tumor gene product: A developmentally regulated transcription factor in the kidney that functions as a tumor suppressor. FASEB Journal, 7, 896-903.
[17] Berger, A.H., Knudson, A.G. and Pandolfi, P.P. (2011) A continuum model for tumour suppression. Nature, 476, 163-169.
[18] Moffett, P., Bruening, W., Nakagama, H., Bardeesy, N., Housman, D., Housman, D.E. and Pelletier, J. (1995) Antagonism of WT1 activity by protein self-association. Proceedings of the National Academy of Sciences of the United States of America, 92, 11105-11109.
[19] Pelletier, J., Bruening, W., Kashtan, C.E., Mauer, S.M., Manivel, J.C., Striegel, J.E., Houghton, D.C., Junien, C., Habib, R., Fouser, L., Fine, R.N., Silverman, B.L., Haber1, D.A. and David Housman, D. (1991) Germline mutations in the Wilms’ tumor suppressor gene are associated with abnormal urogenital development in Denys-Drash syndrome. Cell, 67, 437-447.
[20] Klamt, B., Koziell, A., Poulat, F., Wieacker, P., Scambler, P., Berta, P. and Gessler, M. (1998) Frasier syndrome is caused by defective alternative splicing of WT1 leading to an altered ratio of WT1 +/-KTS splice isoforms. Human Molecular Genetics, 7, 709-714.

Copyright © 2023 by authors and Scientific Research Publishing Inc.

Creative Commons License

This work and the related PDF file are licensed under a Creative Commons Attribution 4.0 International License.